Francesc X. Aymerich
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthetic MRI in Progressive MS: Associations with Disability.
Journal: AJNR. American journal of neuroradiology
Published: March 13, 2024
Estimation of the density of veins from susceptibility-weighted imaging by using Mamdani fuzzy-type rule-based system. Investigating the neurovascular coupling in migraine.
Journal: NeuroImage. Clinical
Published: March 06, 2023
Response to the letter synthetic double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images showed better delineation of multiple sclerosis plaques.
Journal: Neuroradiology
Published: September 06, 2022
Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: February 04, 2022
Assessment of 2D conventional and synthetic MRI in multiple sclerosis.
Journal: Neuroradiology
Published: January 03, 2022
Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 03, 2021
Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.
Journal: AJNR. American journal of neuroradiology
Published: August 08, 2017
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Journal: European radiology
Published: April 06, 2016
Fuzzy approach toward reducing false positives in the detection of small multiple sclerosis lesions in magnetic resonance images.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: January 19, 2012
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Journal: Archives of neurology
Published: November 16, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026